参考文献/References:
[1]Oike T, Suzuki Y, Sugawara K, et al. Radiotherapy plus con-comitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results [J]. PLoS One, 2013, 8(11): e78943.
[2]Fisher PG, Buffler PA. Malignant gliomas in 2005: where to go from here [J]. JAMA, 2005, 293: 615-617.
[3]Reardon DA, Rich JN, Friedman HS, et al. Recent advances in the treatment of malignant astrocytoma [J]. J Clin Oncol, 2006, 24: 1253-1265.
[4]Kortmann RD, Jeremic B, Weller M, et al. Radiochemotherapy of malignant glioma in adults [J]. Clin Exp Strahlenther Onkol, 2003, 179: 219-232.
[5]DeAngelis LM. Brain tumors [J]. N Engl J Med, 2001, 344:114-123.
[6]MahaleyMS, Mettlin C, Natarajan N, et al. National survey of patterns of care for brain-tumor patients [J]. J Neurosurg, 1989, 71: 826-836.
[7]Miranda-Castro R, de-Los-Santos-álvarez N, Lobo-Casta?ón MJ. Long noncoding RNAs: from genomic junk to rising stars in the early detection of cancer [J]. Anal Bioanal Chem, 2019, 411(19): 4265-4275.
[8]Kornienko AE, Guenzl PM, Barlow DP, et al. Gene regulation by the act of long non-coding RNA transcription [J]. BMC Biol, 2013, 11: 59.
[9]Lau E. Non-coding RNA: zooming in on lncRNA functions [J]. Nat Rev Genet, 2014, 15: 3795.
[10]Zhang X, Hamblin MH, Yin KJ. The long noncoding RNA Malat1: its physiological and pathophysiological functions [J]. RNA Biol, 2017, 14(12): 1705-1714.
[11]Voce DJ, Bernal GM, Wu L, et al. Temozolomide treatment induces lncRNA MALAT1 in an NF-κB and p53 codependent manner in glioblastoma [J]. Cancer Res, 2019, 79(10): 2536-2548.
[12]Kim SS, Harford JB, Moghe M, et al. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide [J]. Nucleic Acids Res, 2018, 46(3): 1424-1440.
[13]Cai T, Liu Y, Xiao J, et al. Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma [J]. Cancer Med, 2018, 7(4): 1404-1415.
[14]Takahashi K, Yan I, Haga H, et al. Long noncoding RNAin liver diseases [J]. Hepatology, 2014, 60(2): 744-753.
[15]He Y, Meng XM, Huang C, et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma [J]. Cancer Lett, 2013, 344(1): 20-27.
[16]Duan SB, Li M, Wang ZF, et al. H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling [J]. Onco Targets Ther, 2018, 11: 6395-6404.
[17]Jia LW, Tian YH, Chen YH, et al. The silencing of lncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway [J]. Onco Targets Ther, 2018, 11: 313-321.
[18]Baldinu P, Cossu A, Manca A, et al. Identification of a novelcandidate gene, CASC2, in a regionof common allelic loss at ehro-mosome 10q26 in human endometrial cancer [J]. Hum Mutat, 2004, 23(4): 318-326.
[19]Liao YW, Shen LF, Zhao HT, et al. LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway [J]. J Cell Biochem, 2017, 118(7): 1889-1899.
[20]Jiang CM, Shen F, Du JM, et al. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression [J]. Biomed Pharmacother, 2018, 97: 844-850.
[21]Qi P, Xu MD, Ni SJ, et al. Low expression ofloe285194 is associated with poor prognosis in colometal cancer [J]. J Transl Med, 2013, 11(1): 1-7.
[22]Qi P, Xu MD, Shen XH, et al. Reciprocal repression between tusc 7 and mir-23b in gastric cancer [J]. Int J Cancer, 2015, 137(6): 1269-1278.
[23]Shang C, Tang W, Pan C, et al. Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma [J]. Cancer Chemother Pharmacol, 2018, 81(4): 671-678.
[24]Xu NB, Liu BY, Lian CL, et al. Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma [J]. Cell Death Dis, 2018, 9(12): 1139.
[25]Chen WL, Chen HJ, Hou GQ, et al. LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma [J]. Aging (Albany NY), 2019, 11(16): 6053-6068.
[26]Gu NB, Wang XL, Di ZL, et al. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis [J]. Aging (Albany NY), 2019, 11(22): 10266-10283.
[27]Shangguan WB, Lv XY, Tian N, et al. FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O6-methylguanine-DNA methyltransferase-dependent manner [J]. Korean J Physiol Pharmacol, 2019, 23(6): 475-482.
[28]Mazor G, Levin L, Picard D, et al. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells [J]. Cell Death Dis, 2019, 10(3): 246.
[29]Chen MS, Cheng YY, Yuan ZH, et al. NCK1-AS1 increases drug resistance of glioma cells to temozolomide by modulating miR-137/TRIM24 [J]. Cancer Biother Radiopharm, 2020, 35(2): 101-108.
[30]Lennox KA, Behlke MA. Cellular localization of long noncoding RNAs affects silencing by RNAi more than by antisense oligonucleotides [J]. Nucleic Acids Res, 2016, 44(2): 863-877.
[31]Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses [J]. Nucleic Acids Res, 2017, 36(4): 98-102.
[32]Ma YG, Zhou GH, Li MY, et al. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway [J]. Neurochem Int, 2018, 118: 233-241.
[33]Yang GL, Han BH, Feng T, et al. ZFAS1 knockdown inhibits viability and enhances cisplatin cytotoxicity by upregulating miR-432-5p in glioma cells [J]. Basic Clin Pharmacol Toxicol, 2019, 125(6): 518-526.
[34]Zhang BL, Fang SK, Cheng YY, et al. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway [J]. Aging (Albany NY), 2019, 11(19): 8239-8253.
[35]Zhou H, Ma YB, Zhong DQ, et al. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204 [J]. Biomed Pharmacother, 2019, 112: 108633.
[36]胡 洋，李智星，王 果，等. 长链非编码 RNA 与结直肠癌耐药的研究进展[J]. 中国临床药理学与治疗学，2018，23（4）：456-463.
[37]Song TJ, Yan L, Cai KR, et al. Downregulation of long non coding RNA PVT1 attenuates paclitaxel resistance in glioma cells [J]. Cancer Biomark, 2018, 23(3): 447-453.
[38]Li JY, Ji XJ, Wang HD, et al. Targeting long noncoding RNA HMMR-AS1 suppresses and radiosensitizes glioblastoma [J]. Neoplasia, 2018, 20(5): 456-466.
[39]周原世，李 响，姜兴明，等. 前列腺癌相关转录因子 1在恶性肿瘤中的研究进展[J]. 中国临床医学，2019，26（1）：126-131.
[40]Zhang PH, Liu Y, Fu CY, et al. Knockdown of long noncoding RNA PCAT1 in glioma stem cells promotes radiation sensitivity [J]. Med Mol Morphol, 2019, 52(2): 114-122.
[41]Wang YP, Li HQ, Chen JX, et al. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis [J]. Eur Rev Med Pharmacol Sci, 2020, 24(6): 3190-3203.
[42]李雪元，刘乾坤，袁善鹏，等. 沉默lncRNA GIHCG通过上调miR-146a-3p增加胶质瘤细胞放射敏感性[J]. 中华放射肿瘤学杂志，2020，29（1）：52-56.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(07):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(07):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(07):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(07):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(07):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(07):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(07):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(07):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]谈胤求 陈谦学 张红波 吴 鹏 李云涛 王栋良 袁凡恩.长链非编码RNA PVT1对人脑胶质瘤U251细胞增殖能力的影响[J].中国临床神经外科杂志,2016,(10):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
TAN Yin-qiu,CHEN Qian-xue,ZHANG Hong-bo,et al.Effect of lncRNA-PVT1 on proliferation of glioma U251 cells[J].,2016,(07):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
[12]陈 波 云亚滨 杜俊峰 王伟志.lncRNA SNHG16对胶质瘤U251细胞增殖、侵袭和迁移的影响[J].中国临床神经外科杂志,2020,(11):771.[doi:doi:10.13798/j.issn.1009-153X.2020.11.012]
CHEN Bo,YUN Ya-bin,DU Jun-feng,et al.Effect of lncRNA SNHG16 on proliferation, invasion and migration of glioma U251 cells[J].,2020,(07):771.[doi:doi:10.13798/j.issn.1009-153X.2020.11.012]
[13]孙青青 任洪波 牛国栋.lncRNA SNHG16在人脑胶质瘤组织中的表达及其与病人预后的关系[J].中国临床神经外科杂志,2020,(12):831.[doi:10.13798/j.issn.1009-153X.2020.12.005]
SUN Qing-qing,REN Hong-bo,NIU Guo-dong..Expression of lncRNA SNHG16 in human glioma tissues and its relationship with prognosis of glioma patients[J].,2020,(07):831.[doi:10.13798/j.issn.1009-153X.2020.12.005]
[14]郑江林 王 旋 汪珉杰 姜晓兵.人脑胶质瘤lncRNA PIK3CD-AS2表达及临床意义[J].中国临床神经外科杂志,2021,26(09):687.[doi:10.13798/j.issn.1009-153X.2021.09.011]
ZHENG Jiang-lin,WANG Xuan,WANG Min-jie,et al.Expression of lncRNA PIK3CD-AS2 in human brain gliomas and its clinical significance[J].,2021,26(07):687.[doi:10.13798/j.issn.1009-153X.2021.09.011]
[15]李占成 石 铁 周卫忠.胶质瘤自噬相关长链非编码RNA的生信分析[J].中国临床神经外科杂志,2021,26(11):839.[doi:10.13798/j.issn.1009-153X.2021.11.007]
LI Zhan-cheng,SHI Tie,ZHOU Wei-zhong.Autophagy-related long non-coding RNA signature in glioma patients based on bioinformatics analysis[J].,2021,26(07):839.[doi:10.13798/j.issn.1009-153X.2021.11.007]
[16]杨帆,综述,张剑宁,等.长链非编码RNA在胶质瘤中的研究进展[J].中国临床神经外科杂志,2022,27(06):508.[doi:10.13798/j.issn.1009-153X.2022.06.028]
[17]王昆鹏,张建党,董孟宁,等.lncRNA SNHG7对胶质瘤细胞侵袭、迁移的影响[J].中国临床神经外科杂志,2022,27(08):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
WANG Kun-peng,ZHANG Jian-dang,DONG Meng-ning,et al.[J].,2022,27(07):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
[18]丁萌,王红娟,周洁,等.lncRNA ZNF674-AS1过表达对胶质瘤U87细胞增殖、侵袭和迁移的影响[J].中国临床神经外科杂志,2022,27(10):837.[doi:10.13798/j.issn.1009-153X.2022.10.012]
DING Meng,WANG Hong-juan,Zhou Jie,et al.Effects of over-expression of lncRNA ZNF674-AS1 on proliferation, invasion and migration of U87 glioma cells[J].,2022,27(07):837.[doi:10.13798/j.issn.1009-153X.2022.10.012]